Research & Development Laboratories near Winisk ON (115 Result(s))

The Certispec Group of companies is pleased to be able to offer independent marine surveying, inspection, sampling and laboratory testing services throughout Canada and other parts of the globe. With our ever expanding list of international offices and also through working agreements with a number of global inspection companies, we are also able to offer a truly world-wide service for a wide range of commodities. All of our personnel are well qualified and have many years of experience in surveying, inspection and testing both here and in other parts of the world. We have adopted our own Quality Assurance Program (Q.P.) which has been successfully registered to the ISO 9001:2008 Standard at our Burnaby and Montreal locations.

COREALIS Pharma recognizes the uniqueness of each API of each therapeutic application the regulatory requirements of each country and of each client. Thus, personalized, efficient, and supported service is the priority.

MUHC Vaccine Study Centre website. Here, you will find information on our current and upcoming studies at our Clinic located in Pierrefonds. Since 1991, we have conducted over 75 studies over 5000 participants and have a proven track record in enrolling and conducting quality vaccine & epidemiological research. We have a bilingual, cohesive research team whose members work.

Polystochastic During many years of basic and applied research and development at different universities research institutions, and companies in Europe and North America we developed in the framework of constructivism the polystochastic modeling approach for technologies, devices, products methodologies and enterprises to render them capable to challenge and cross the complexity frontier.

Often, pharmaceutical companies avoid new laboratory testing methodologies preferring to stick to established procedures for drug development so as to avoid any potential regulatory ambiguity. This tendency to avoid new methodologies and regulatory scrutiny sometimes leads to slower progress, higher costs and lower probability of new product approvals. Furthermore, some pharmaceutical firms severely restrict academic research-based modifications to established laboratory testing procedures in drug development because of their concern over triggering costly adjustments to the established regulatory framework.